Cancer-Selective Targeting of the NF-?B Survival Pathway with GADD45ß/MKK7 Inhibitors. (2014)
Attributed to:
Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ccell.2014.11.021
PubMed Identifier: 28898681
Publication URI: http://europepmc.org/abstract/MED/28898681
Type: Journal Article/Review
Volume: 26
Parent Publication: Cancer cell
Issue: 6
ISSN: 1535-6108